Health experts are emphasizing the importance of informing states about clinical trials taking place within their boundaries. Clinical trials play a crucial role in the development of new drugs and medical treatments. However, experts are highlighting the need for better communication and transparency between researchers conducting clinical trials and the state governments. This call for improved information sharing comes in the wake of concerns about the ethical conduct of clinical trials and the need to ensure the safety and well-being of participants. By keeping state governments informed about ongoing clinical trials, researchers can enhance oversight and accountability in the process. This move can also help in addressing any potential issues or challenges that may arise during the trial phase. Additionally, involving state authorities in the clinical trial process can lead to better coordination and cooperation, ultimately benefiting the healthcare system as a whole. As India continues to play a significant role in the global pharmaceutical industry, ensuring the smooth conduct of clinical trials is essential for maintaining the country’s reputation and attracting further investment. Therefore, experts are urging all stakeholders involved in clinical trials to prioritize transparency and collaboration with state governments to uphold the highest standards of ethics and safety. In conclusion, by fostering strong partnerships between researchers and state authorities, India can strengthen its position as a leading hub for clinical research and innovation in the healthcare sector.